Marcel Spaargaren, PhD
Academic Medical Center Amsterdam
Marcel Spaargaren obtained his Ph.D. in 1992 at the Hubrecht Institute and the University of Utrecht, Utrecht, the Netherlands. As recipient of a postdoctoral fellowship of the Dutch Cancer Society (KWF) he worked as a visiting scientist at ONYX Pharmaceuticals, Richmond CA, USA, and as a postdoctoral researcher at the dept. of Physiological Chemistry, University Medical Center Utrecht. In 1998 he was appointed assistant professor and staff member at the dept. of Pathology of the Academic Medical Center (AMC) of the University of Amsterdam (UvA). Currently, he is associate professor at the dept. of Pathology at the Amsterdam UMC (location AMC) and board-member of the Lymphoma and Myeloma Center Amsterdam (LYMMCARE). He is also leader of the theme on ‘Target & Therapy Discovery’ (Target & Therapy Discovery CCA) and member of the Research Board of the Cancer Center Amsterdam (CCA), dean of the Oncology Graduate School Amsterdam (OOA), and chair of the society for Cancer Biology of the Dutch Cancer Society (KWF).